Chargement en cours...
Insight into the Development of PET Radiopharmaceuticals for Oncology
While the development of positron emission tomography (PET) radiopharmaceuticals closely follows that of traditional drug development, there are several key considerations in the chemical and radiochemical synthesis, preclinical assessment, and clinical translation of PET radiotracers. As such, we o...
Enregistré dans:
| Publié dans: | Cancers (Basel) |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7281377/ https://ncbi.nlm.nih.gov/pubmed/32455729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051312 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|